LEP and metabolic dysfunction-associated steatotic liver disease: Leptin may exert an anti-steatotic action in early NAFLD by promoting FA oxidation and decreased lipogenesis and a pro-inflammatory and pro-fibrotic action at later disease stages by increasing hepatic reactive oxygen species generation, pro-inflammatory cytokine release, and enhanced fibrinogenesis (28, 29).